Bank of Montreal
CRDL

Bank of Montreal’s Cardiol Therapeutics CRDL Stock Holding History

Bank of Montreal’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,000
Closed -$68K – 3577
2025
Q2 		$68K Sell
50,000
-79
-0.2% -$92 ﹤0.01% 3080
2025
Q1 		$47.7K Buy
50,079
+79
+0.2% +$97 ﹤0.01% 3074
2024
Q4 		$64.3K Hold
50,000
– – ﹤0.01% 3056
2024
Q3 		$103K Sell
50,000
-112
-0.2% -$232 ﹤0.01% 3238
2024
Q2 		$106K Buy
50,112
+112
+0.2% +$238 ﹤0.01% 3218
2024
Q1 		$105K Sell
50,000
-54,479
-52% -$73.4K ﹤0.01% 3271
2023
Q4 		$101K Sell
104,479
-6,675
-6% -$5.67K ﹤0.01% 3375
2023
Q3 		$107K Sell
111,154
-1,025
-0.9% -$979 ﹤0.01% 3260
2023
Q2 		$110K Buy
112,179
+1,700
+2% +$1.12K ﹤0.01% 3425
2023
Q1 		$59.3K Buy
110,479
+20,479
+23% +$12.1K ﹤0.01% 3339
2022
Q4 		$61.2K Buy
90,000
+75,269
+511% +$45.9K ﹤0.01% 3492
2022
Q3 		$15 Buy
+14,731
New +$18K ﹤0.01% 3832
2022
Q2 		– Sell
-8,731
Closed -$13K – 4145
2022
Q1 		$13K Buy
+8,731
New +$14.4K ﹤0.01% 3976

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of Montreal's CRDL Position: Q3 2025 in Review

Bank of Montreal sold out of Cardiol Therapeutics (CRDL) in Q3 2025, closing a stake of 50,000 shares — an estimated $68K sold.

Bank of Montreal first reported a position in CRDL in Q1 2022 and held it in 13 quarters. The position peaked at $110K in Q2 2023. 48 funds tracked by Wall St. Rank hold CRDL as of Q3 2025.

  • Bank of Montreal reported no remaining Cardiol Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 50,000 Cardiol Therapeutics shares in Q3 2025, an estimated $68K.
  • Bank of Montreal first reported a position in Cardiol Therapeutics in Q1 2022 and held it in 13 quarters.
  • Bank of Montreal's Cardiol Therapeutics position peaked at $110K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.